These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19416224)

  • 1. Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia.
    Unemori E; Sibai B; Teichman SL
    Ann N Y Acad Sci; 2009 Apr; 1160():381-4. PubMed ID: 19416224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.
    Conrad KP
    Hum Reprod Update; 2016 Sep; 22(5):647-64. PubMed ID: 27385360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical evaluation of the distribution of vascular endothelial growth factor in the placenta, placental bed in normal pregnancy and in women with preeclampsia].
    Milovanov AP; Sidorova IS; Solonitsyn AN; Borovkova EI
    Arkh Patol; 2008; 70(3):12-5. PubMed ID: 18727425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia.
    Aris A; Benali S; Ouellet A; Moutquin JM; Leblanc S
    Placenta; 2009 Apr; 30(4):342-7. PubMed ID: 19223072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global impact of pre-eclampsia and eclampsia.
    Duley L
    Semin Perinatol; 2009 Jun; 33(3):130-7. PubMed ID: 19464502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial.
    Dschietzig T; Teichman S; Unemori E; Wood S; Boehmer J; Richter C; Baumann G; Stangl K
    J Card Fail; 2009 Apr; 15(3):182-90. PubMed ID: 19327619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic factors and preeclampsia.
    Steinberg G; Khankin EV; Karumanchi SA
    Thromb Res; 2009; 123 Suppl 2():S93-9. PubMed ID: 19217486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hemodynamic effects of relaxin in humans.
    Smith M; Davison J; Conrad K; Danielson L
    Ann N Y Acad Sci; 2005 May; 1041():163-72. PubMed ID: 15956702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First clinical experience with intravenous recombinant human relaxin in compensated heart failure.
    Dschietzig T; Teichman S; Unemori E; Wood S; Boehmer J; Richter C; Baumann G; Stangl K
    Ann N Y Acad Sci; 2009 Apr; 1160():387-92. PubMed ID: 19416226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial.
    Manzur-Verástegui S; Mandeville PB; Gordillo-Moscoso A; Hernández-Sierra JF; Rodríguez-Martínez M
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):580-5. PubMed ID: 18070142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the magnesium aspartate hydrochloride administration to the maternal circuit on the aspartate concentration of the fetal circuit under in vitro perfusion of human placenta.
    Malek A; Leiser R
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):12-7. PubMed ID: 18951687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model.
    Haase N; Golic M; Herse F; Rugor J; Linz D; Solano ME; Müller DN; Dechend R
    PLoS One; 2016; 11(3):e0150743. PubMed ID: 26963382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin (Connetics/Celltech).
    Jones R
    IDrugs; 2001 Feb; 4(2):206-17. PubMed ID: 16032483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of relaxin in maternal systemic and renal vascular adaptations during gestation.
    McGuane JT; Debrah JE; Debrah DO; Rubin JP; Segal M; Shroff SG; Conrad KP
    Ann N Y Acad Sci; 2009 Apr; 1160():304-12. PubMed ID: 19416209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].
    Stepan H; Jank A
    Z Geburtshilfe Neonatol; 2009 Jun; 213(3):101-5. PubMed ID: 19536710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental ischemia and breast cancer risk after preeclampsia: tying the knot.
    Gingery A; Bahe EL; Gilbert JS
    Expert Rev Anticancer Ther; 2009 May; 9(5):671-81. PubMed ID: 19445583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of blood pressure mean and its correlation with renal function in patients with severe preeclampsia treated with three oral antihypertensive agents].
    Vázquez Rodríguez JG
    Ginecol Obstet Mex; 2009 May; 77(5):219-26. PubMed ID: 19496516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin: an endogenous renoprotective factor?
    Hewitson TD; Samuel CS
    Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic modulation of placental chorionic plate artery reactivity by reactive oxygen species.
    Mills TA; Wareing M; Shennan AH; Poston L; Baker PN; Greenwood SL
    Free Radic Biol Med; 2009 Jul; 47(2):159-66. PubMed ID: 19389471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.